PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) will report first quarter 2026 financial results on Thursday, May 7, 2026 at 4:30 p.m. ET via a live webcast and conference call. The company will provide a business update and outlook during the event.
A replay will be available on the company's Investors "Events & Presentations" page for 30 days; phone participation requires advance registration for dial-in details.
Positive
- None.
Negative
- None.
News Market Reaction – PTCT
In the Apr 22 session, PTCT gained 0.31%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Earnings date set | Neutral | -2.1% | Announcement of date and time for Q4 and full-year 2025 results webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The prior earnings date announcement saw a modest negative move, suggesting that earnings scheduling releases for PTCT have not historically been clear positive catalysts.
Over recent months, PTC Therapeutics reported strong 2025 financials, including total revenues of $1.731B and year-end cash of $1.945B, alongside a profitable Novartis collaboration. It has also issued multiple inducement equity grants and added an experienced biotech banker to its board. The current announcement simply sets the May 7, 2026 webcast date for Q1 2026 results, mirroring the prior pattern where an earnings date notice on Feb. 5, 2026 preceded full-year 2025 results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of the PTC website. A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advance here to receive dial-in details.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-302749730.html
SOURCE PTC Therapeutics, Inc.